RECRUITING

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

Talk to us

Conditions

OncologyMyeloid Leukemia, AcuteCancerolder adultsgeriatric oncologycaregivers

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a multicenter randomized controlled trial that assesses the efficacy of a decisional intervention \[University of Rochester-Geriatric Oncology assessment for Acute myeloid Leukemia (UR-GOAL)\] compared to an attention control.

Official Title

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

Quick Facts

Study Start:2025-07-11
Study Completion:2030-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06697600

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥60 years (from date of consent, confirmed on electronic medical records)
  2. * A new diagnosis of AML
  3. * Diagnosis can be based on the International Consensus Classification or World Health Organization
  4. * Myeloid sarcoma is allowed
  5. * AML with central nervous system involvement is allowed
  6. * Cancer-directed treatment has not started
  7. * Treatment to temporarily decrease white blood cells is acceptable; these may include hydroxyurea, leukapheresis, or cytarabine
  8. * Intrathecal chemotherapy is acceptable
  9. * The patient's oncologist has been or will be enrolled on the study
  10. * English or Spanish-speaking
  11. * Patients without a caregiver will still be eligible to participate in the study Exclusion criteria
  12. * A diagnosis of acute promyelocytic leukemia
  13. * Patients with psychiatric or cognitive conditions which the treating oncologist believes prohibits informed consent or compliance with study procedures
  14. * Prior cancer-directed treatment for AML
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Kah Poh Loh
CONTACT
585-276-4353
Kahpoh_Loh@URMC.Rochester.edu
Becky Gravenstede
CONTACT
585-727-4728
becky_gravenstede@urmc.rochester.edu

Study Locations (Sites)

University of Alabama at Birmingham, Division of Hematology and Oncology
Birmingham, Alabama, 35233
United States
University of Rochester Medical Center
Rochester, New York, 14642
United States
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27514
United States
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Section of Hematology/Oncology
Winston-Salem, North Carolina, 27157
United States

Collaborators and Investigators

Sponsor: University of Rochester

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-11
Study Completion Date2030-06-01

Study Record Updates

Study Start Date2025-07-11
Study Completion Date2030-06-01

Terms related to this study

Keywords Provided by Researchers

  • older adults
  • geriatric oncology
  • caregivers

Additional Relevant MeSH Terms

  • Oncology
  • Myeloid Leukemia, Acute
  • Cancer